Cleerly’s Proxy Solution to Improve Heart Disease Imaging Workflows

Nick  Nieslanik,  Chief Technology Officer at Cleerly, the company creating a new standard of care for heart disease, discusses Cleerly Proxy. The Proxy software allows Cleerly to seamlessly transmit heart disease imaging data to care providers by automating the upload of coronary computed tomography angiography (CCTA) scans of patients’ hearts from local systems to Cleerly’s cloud service. The solution removes the need for physicians and providers to have multiple systems and workflows, and allows them to focus on the priority, heart disease detection, using Cleerly’s reporting and analytics insights.

Nick Nieslanik is a technology leader with a wealth of experience in building teams, delivering high quality products and developing new technologies that improve people’s lives. Before Cleerly, Nieslanik served as vice president of engineering at Teladoc Health, where he was focused on integrating chronic condition and behavioral health capabilities into the Teladoc telemedicine platform. Nieslanik transitioned to Teladoc from Livongo during its $3.4 billion IPO, where he served as senior director of engineering. He joined the Livongo team after he was head of engineering at myStrength, a behavioral health startup providing self-service digital tools and content in areas such as depression and anxiety. In that position, he built the myStrength platform and technology organization from the ground up, leading to the acquisition of the company by Livongo in 2019. At Cleerly, Nieslanik drives Cleerly’s technical and product strategies, focusing on innovative new solutions in engineering and data science, and driving the effectiveness of technology resources across the enterprise. Nieslanik holds a Bachelor of Science degree in Electrical and Computer Engineering from the University of Colorado at Boulder.

Liked it? Take a second to support healthprofessionalradio on Patreon!
Become a patron at Patreon!


Leave a Reply

You must be logged in to post a comment.